中文版 | English

个人主页

关键词云

成果统计

合作作者[TOP 5]

  • 王皞鹏

    合作成果数：12

  • 王月桐

    合作成果数：9

  • 王飞

    合作成果数：7

  • 朱小童

    合作成果数：7

  • Tonks, Nicholas K.

    合作成果数：7

访问统计


  总访问量
 2672
  访问来源
    内部： 25
    外部： 2647
    国内： 2379
    国外： 293

  年访问量
 202
  访问来源
    内部： 0
    外部： 202
    国内： 186
    国外： 16

  月访问量
 78
  访问来源
    内部： 0
    外部： 78
    国内： 74
    国外： 4

访问量

访问量

1. Induction of senescence-associated secretory phenotype underlies t.. [1278]
2. De novo synthesis and salvage pathway coordinately regulate polyam.. [891]
3. Tuning charge density of chimeric antigen receptor optimizes tonic.. [878]
4. THEMIS is a substrate and allosteric activator of SHP1, playing du.. [752]
5. Biallelic Mutations in MYORG Cause Autosomal Recessive Primary Fam.. [707]
6. CRISPR system: Discovery, development and off-target detection [682]
7. FER-mediated phosphorylation and PIK3R2 recruitment on IRS4 promot.. [605]
8. Addressing the Enzyme-independent tumor-promoting function of NAMP.. [575]
9. Chimeric Antigen Receptor Designed to Prevent Ubiquitination and D.. [567]
10. Suppression of protein tyrosine phosphatase N23 predisposes to bre.. [550]
11. Key elements for designing and performing a CRISPR/Cas9-based gene.. [536]
12. 基于NAMPT靶蛋白的蛋白降解化合物及其应用 [521]
13. NAD(+) supplement potentiates tumor-killing function by rescuing d.. [514]
14. PINX1 loss confers susceptibility to PARP inhibition in pan-cancer.. [501]
15. Protein tyrosine phosphatase receptor type R (PTPRR) antagonizes t.. [500]
16. Spatial regulation of signaling by the coordinated action of the p.. [494]
17. NAMPT-targeting PROTAC and nicotinic acid co-administration elicit.. [445]
18. Allosterically inhibited PFKL via prostaglandin E2 withholds gluco.. [431]
19. 一种酪氨酸磷酸酶底物鉴定方法 [364]
20. Development of the nonreceptor tyrosine kinase FER-targeting PROTA.. [363]
21. 专访信号转导领域青年学者——范高峰研究员 [351]
22. 基于NAMPT靶蛋白的蛋白降解复合物及其应用 [345]
23. Visible Light-Responsive Hydrogels for Cellular Dynamics: A Dual M.. [330]
24. NAD+和//或NAD+抑制剂和//或NAD+激动剂的用途及其联合制剂 [322]
25. Development of the non-receptor tyrosine kinase FER-targeting PROT.. [319]
26. Legionella effector LnaB is a phosphoryl-AMPylase that impa.. [300]
27. USES OF NAD+ AND//OR NAD+ INHIBITORS AND//OR NAD+ AGONISTS AND COM.. [296]
28. Discovery of Trametinib as an orchestrator for cytoskeletal viment.. [278]
29. USES OF NAD+ AND//OR NAD+ INHIBITORS AND//OR NAD+ AGONISTS AND COM.. [276]
30. Minimizing DNA trapping while maintaining activity inhibition via .. [275]
31. Addressing Enzymatic-Independent Tumor-Promoting Function of NAMPT.. [260]
32. Use of NAD+ and//or NAD+ inhibitors and // or NAD+ agonists and co.. [249]
33. Emerging strategies to overcome PARP inhibitors' resistance in ova.. [243]
34. Visible light-responsive hydrogels for cellular dynamics and spati.. [87]

下载量

1. De novo synthesis and salvage pathway coordinately regulate polyam.. [289]
2. Induction of senescence-associated secretory phenotype underlies t.. [284]
3. Tuning charge density of chimeric antigen receptor optimizes tonic.. [263]
4. PINX1 loss confers susceptibility to PARP inhibition in pan-cancer.. [94]
5. Addressing Enzymatic-Independent Tumor-Promoting Function of NAMPT.. [76]
6. Chimeric Antigen Receptor Designed to Prevent Ubiquitination and D.. [27]
7. NAMPT-targeting PROTAC and nicotinic acid co-administration elicit.. [26]
8. Addressing the Enzyme-independent tumor-promoting function of NAMP.. [24]
9. Allosterically inhibited PFKL via prostaglandin E2 withholds gluco.. [14]
10. Protein tyrosine phosphatase receptor type R (PTPRR) antagonizes t.. [13]
11. CRISPR system: Discovery, development and off-target detection [11]
12. Emerging strategies to overcome PARP inhibitors' resistance in ova.. [11]
13. Visible light-responsive hydrogels for cellular dynamics and spati.. [11]
14. Spatial regulation of signaling by the coordinated action of the p.. [9]
15. THEMIS is a substrate and allosteric activator of SHP1, playing du.. [7]
16. Development of the nonreceptor tyrosine kinase FER-targeting PROTA.. [6]
17. Discovery of Trametinib as an orchestrator for cytoskeletal viment.. [6]
18. Minimizing DNA trapping while maintaining activity inhibition via .. [6]
19. Key elements for designing and performing a CRISPR/Cas9-based gene.. [5]
20. FER-mediated phosphorylation and PIK3R2 recruitment on IRS4 promot.. [5]
21. Legionella effector LnaB is a phosphoryl-AMPylase that impa.. [5]
22. Development of the non-receptor tyrosine kinase FER-targeting PROT.. [4]
23. Suppression of protein tyrosine phosphatase N23 predisposes to bre.. [3]
24. 基于NAMPT靶蛋白的蛋白降解复合物及其应用 [3]
25. 一种酪氨酸磷酸酶底物鉴定方法 [2]
26. 基于NAMPT靶蛋白的蛋白降解化合物及其应用 [2]
27. Biallelic Mutations in MYORG Cause Autosomal Recessive Primary Fam.. [1]
28. USES OF NAD+ AND//OR NAD+ INHIBITORS AND//OR NAD+ AGONISTS AND COM.. [1]